ePoster

SHARED AND SUBTYPE-SPECIFIC SERUM PROTEOMIC SIGNATURES IN SMALL CELL AND NON-SMALL CELL LUNG CANCER

Yaren Aydoganand 6 co-authors

Regenerative and Restorative Medical Research Center (REMER), Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS05-09AM-532

Presentation

Date TBA

Board: PS05-09AM-532

Poster preview

SHARED AND SUBTYPE-SPECIFIC SERUM PROTEOMIC SIGNATURES IN SMALL CELL AND NON-SMALL CELL LUNG CANCER poster preview

Event Information

Poster Board

PS05-09AM-532

Abstract

Lung cancer is a highly lethal disease caused by genetic alterations in the bronchial epithelium and accounts for approximately 18% of cancer-related deaths worldwide. It is classified into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). The aim of this study was to identify serum proteins that are commonly or differentially altered between lung cancer subtypes and to evaluate their potential as circulating biomarkers. Serum samples from healthy controls, SCL, and NSCLC patients were subjected to depletion of most abundant proteins to improve proteome coverage, followed by liquid chromatography tandem mass spectrometry based proteomic analysis. The analysis showed that 63 proteins were significantly altered in both SCLC and NSCLC compared with controls, while 20 proteins in SCLC and 21 proteins in NSCLC showed subtype specific changes. Proteins commonly altered in both subtypes were associated with acute phase response, lipid metabolism and systemic inflammatory regulation, including albumin, haptoglobin, apolipoproteins A2 and A4, transthyretin, ALPHA 1 acid glycoproteins 1 and 2, complement components and glycolytic enzymes, indicating a shared cancer associated systemic response between SCLC and NSCLC. In contrast, SCLC displayed a distinct serum proteomic network characterized by enhanced innate immune and complement activation involving C1qa, C3, apolipoprotein C1 and cathepsin D. A direct interaction between serum amyloid A1 and serum amyloid A2 was uniquely observed in SCLC. In conclusion, while SCLC and NSCLC share a common systemic proteomic signature, SCLC is distinguished by a pronounced innate immune complement and acute phase axis, highlighting potential subtype specific circulating biomarkers.

Recommended posters

NON-CODING RNA PROFILING IN SERUM, CSF, OLFACTORY MUCOSA, TEARS AND SKIN IDENTIFIES NOVEL MOLECULAR SIGNATURES IN AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA

Giorgia Farinazzo, Carlotta Tiranzoni, Ilaria Linda Dellarole, Arianna Ciullini, Federico Cazzaniga, Linda Maldera, Giorgio Gelosa, Vittoria Aprea, Giacomina Rossi, Federico Verde, Paola Caroppo, Maria Vizziello, Andrea Giordano, Nilo Riva, Eleonora Dalla Bella, Fabio Moda, Erika Salvi, Stefania Marcuzzo

TOWARD PRECISION MEDICINE IN AMYOTROPHIC LATERAL SCLEROSIS: BLOOD-BASED TRANSCRIPTOMIC BIOMARKER DISCOVERY

Asif Anamta, Gulzar Fatima, Sekaran Karthik, Hatem Zayed

METABOLOMIC AND PROTEOMIC PROFILING REVEAL RECOVERY-RELATED SERUM SIGNATURES IN SPINAL CORD INJURY PATIENTS UNDER REHABILITATION

Barbara M de Sousa, Marisa Costa, Fernando García, Abida Islam Pranty, Javier Muñoz, Fátima Gandarez, James Adjaye, Alexandra Nunes, Maria Ribeiro-Cunha, Sandra I. Vieira

SERUM 1H-NMR METABOLOMIC PROFILING DISTINGUISHES OCB TYPE 1 AND TYPE 2 PATTERNS IN EARLY POSSIBLE MULTIPLE SCLEROSIS

Pinar Sengul, Ahmet Tarik Baykal, Mustafa Serteser

PLASMA PROTEOLYTIC IMBALANCE AS A SIGNATURE TO DIFFERENTIATE ALZHEIMER’S DISEASE FROM FRONTOTEMPORAL AND LEWY BODY DEMENTIAS

Miren Ettcheto, Patricia Regina Manzine, Marina Mantellatto Grigoli, Suelen Santos Alves, Norberto Garcia-Cairasco, Karina Braga Gomes, Paulo Caramelli, Vitor Tumas, Antoni Camins, Fabiana de Souza Orlandi, Marcia Regina Cominetti

INVESTIGATING THE PERIPHERAL IMMUNE LANDSCAPE OF NEUROCOVID: A SINGLE-CELL TRANSCRIPTOMICS AND PLASMA PROTEOMICS APPROACH TOWARD CLINICAL STRATIFICATION

Bidour Hussein, Celia L. Hartmann, Jessica V. Montgomery, Francesca Calcaterra, Susan Seibert, Federico Masserini, Omid Shirvani, Aleksej Frolov, NeuroCOV Consortium, Christiana Franke, Agostino Riva, Harald Prüß, Gabor Petzold, Domenico Mavilio, Elena De Domenico, Joachim L. Schultze, Marc D. Beyer, Caterina Carraro, Anna C. Aschenbrenner

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.